Antifungal Drug Susceptibility and Genetic Characterization of Fungi Recovered from COVID-19 Patients.
Ontology highlight
ABSTRACT: Fungal infections are common complications of respiratory viral infections and are associated with the increased need for intensive care and elevated mortality. Data regarding microbiological and molecular characteristics of such infections in COVID-19 patients are scarce. Here, we performed a comprehensive analysis, including species identification, antifungal susceptibility testing, molecular resistance determinants analysis, typing, and retrospective clinical data review, of fungal isolates recovered from 19 COVID-19 patients, who were hospitalized at the Hackensack University Medical Center (HUMC) in Hackensack, New Jersey, USA, in the initial phase of the pandemic from April-May 2020. In total, 17 Candida albicans, two C. parapsilosis, and two Aspergillus fumigatus
SUBMITTER: Kordalewska M
PROVIDER: S-EPMC8306261 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA